About Affect Therapeutics
Services
Type of Care
Substance use treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
In-network prescribing entity; Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity; Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Lofexidine or Clonidine detoxification
Pharmacotherapies
Acamprosate (Campral®); Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (oral); Clonidine; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Contingency management/motivational incentives; Motivational interviewing; Matrix Model; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State Substance use treatment agency; State department of health; Commission on Accreditation of Rehabilitation Facilities (CARF)
Payment/Insurance/Funding Accepted
Medicaid; Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid
Assessment/Pre-treatment
Comprehensive substance use assessment; Interim services for clients; Outreach to persons in the community; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Breathalyzer or blood alcohol testing; Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge
Recovery Support Services
Housing services; Assistance with obtaining social services; Mentoring/peer support; Employment counseling or training
Education and Counseling Services
HIV or AIDS education, counseling, or support; Hepatitis education, counseling, or support; Health education services other than HIV/AIDS or hepatitis; Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Group counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Young Adults; Adults
Sex Accepted
Female; Male
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Case management service; Social skills development; Integrated primary care services; Suicide prevention services
Type of Care
Substance use treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
In-network prescribing entity; Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity; Other contracted prescribing entity; No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere; Lofexidine or Clonidine detoxification
Pharmacotherapies
Acamprosate (Campral®); Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (oral); Clonidine; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Contingency management/motivational incentives; Motivational interviewing; Matrix Model; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State Substance use treatment agency; State department of health; Commission on Accreditation of Rehabilitation Facilities (CARF)
Payment/Insurance/Funding Accepted
Medicaid; Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid
Assessment/Pre-treatment
Comprehensive substance use assessment; Interim services for clients; Outreach to persons in the community; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Breathalyzer or blood alcohol testing; Drug or alcohol urine screening
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge
Recovery Support Services
Housing services; Assistance with obtaining social services; Mentoring/peer support; Employment counseling or training
Education and Counseling Services
HIV or AIDS education, counseling, or support; Hepatitis education, counseling, or support; Health education services other than HIV/AIDS or hepatitis; Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Group counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Young Adults; Adults
Sex Accepted
Female; Male
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Case management service; Social skills development; Integrated primary care services; Suicide prevention services
